06896.HK
Golden Throat Holdings Group Company Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 2.28
+0.44%Margins
Gross margin
75.7%
EBITDA margin
37.4%
EBIT margin
32.5%
Net margin
26.8%
FCF margin
22.8%
41.4%
Return on equity
24.9%
Return on assets
35.2%
Return on invested capital
0.96x
Asset turnover
HKD 699.6M
Cash from operations
HKD 1.70
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025